Page last updated: 2024-10-30

mesalamine and Diabetes Mellitus, Type 2

mesalamine has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Din, H1
Anderson, AJ1
Ramos Rivers, C1
Proksell, S1
Koutroumpakis, F1
Salim, T1
Babichenko, D1
Tang, G1
Koutroubakis, IE1
Schwartz, M1
Johnston, E1
Barrie, A1
Harrison, J1
Hashash, J1
Dunn, MA1
Hartman, DJ1
Binion, DG1

Other Studies

1 other study available for mesalamine and Diabetes Mellitus, Type 2

ArticleYear
Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.
    Inflammatory bowel diseases, 2020, 08-20, Volume: 26, Issue:9

    Topics: Adult; Aged; Biological Products; Colitis, Ulcerative; Crohn Disease; Diabetes Mellitus, Type 1; Dia

2020